Articles with public access mandates - Huzaifa I Adamali - Versus Arthritis, UKLearn more
NoteFor this mandate, articles should be available from specific locations.
Not available based on mandate: 4
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
CJ Stock, H Sato, C Fonseca, WAS Banya, PL Molyneaux, H Adamali, ...
Thorax 68 (5), 436-441, 2013
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
D Visca, L Mori, V Tsipouri, S Fleming, A Firouzi, M Bonini, MJ Pavitt, ...
The Lancet Respiratory Medicine 6 (10), 759-770, 2018
In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality
JA Mackintosh, SR Desai, H Adamali, K Patel, F Chua, A Devaraj, ...
European Respiratory Journal 53 (5), 2019
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial
JA Whitty, J Rankin, D Visca, V Tsipouri, L Mori, L Spencer, H Adamali, ...
European Respiratory Journal 55 (2), 2020
Available based on mandate: 3
Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis
AM Russell, H Adamali, PL Molyneaux, PT Lukey, RP Marshall, ...
American journal of respiratory and critical care medicine 194 (8), 989-997, 2016
Ambulatory and shortâburst oxygen for interstitial lung disease
C Sharp, H Adamali, AB Millar
Cochrane Database of Systematic Reviews, 2016
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial
D Visca, V Tsipouri, L Mori, A Firouzi, S Fleming, M Farquhar, E Leung, ...
Trials 18, 1-11, 2017
Publication and funding information is determined automatically by a computer program